Literature DB >> 1441731

Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens.

C L Schumacher1, H C Ertl, H Koprowski, B Dietzschold.   

Abstract

Treatment of mice with a cocktail of murine anti-rabies monoclonal antibodies (mAb-C) interfered with the ability of these animals to mount a virus-neutralizing antibody response to rabies vaccine. Administered mAb-C did not affect the induction of rabies virus-specific T-helper cells. The magnitude of the inhibition of rabies virus-specific B-cell response was dependent on the concentration of the mAb-C and the duration of the mAb-mediated interference was inversely proportional to the biological half-life of the mAb. As long as the serum titres were above a critical threshold, the suppression could not be overcome even by multiple vaccinations. Since injection of mice with immunocomplexes consisting of inactivated rabies virus and mAb rendered the animals non-responsive to a subsequent vaccination with inactivated rabies virus, it is concluded that the mAb-induced suppression might be caused by the formation of antigen-antibody complexes which exert a negative signalling effect to premature B cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1441731     DOI: 10.1016/0264-410x(92)90510-q

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects.

Authors:  H X Lin; C Gontier; M F Saron; P Perrin
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

2.  Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.

Authors:  J Lang; G H Simanjuntak; S Soerjosembodo; C Koesharyono
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

3.  Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.

Authors:  T R Kreil; E Maier; S Fraiss; M M Eibl
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Function and glycosylation of plant-derived antiviral monoclonal antibody.

Authors:  Kisung Ko; Yoram Tekoah; Pauline M Rudd; David J Harvey; Raymond A Dwek; Sergei Spitsin; Cathleen A Hanlon; Charles Rupprecht; Bernhard Dietzschold; Maxim Golovkin; Hilary Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-10       Impact factor: 11.205

5.  Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection.

Authors:  Sanne Terryn; Aurélie Francart; Heidi Rommelaere; Catelijne Stortelers; Steven Van Gucht
Journal:  PLoS Negl Trop Dis       Date:  2016-08-02

6.  Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters.

Authors:  Marie-Clotilde Bernard; Florence Boudet; Andrea-Clemencia Pineda-Peña; Françoise Guinet-Morlot
Journal:  Sci Rep       Date:  2022-04-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.